B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2

Nephrology Dialysis Transplantation

Volumn 15, Issue 4, 2000, Pages 502-510

  Fernández Fresnedo, Gema ^a   Ramos, María Angeles ^a   González Pardo, Maria Consuelo ^a   De Francisco, Angel Luis Martín ^a   López Hoyos, Marcos ^a   Arias, Manuel ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Apoptosis; Bcl 2; Chronic renal failure; Fas; Lymphopenia

Indexed keywords

FAS ANTIGEN; PROPIDIUM IODIDE; PROTEIN BCL 2; BIOLOGICAL MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIALYSIS; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; UREMIA; ADOLESCENT; BLOOD; CELL CULTURE; COMPARATIVE STUDY; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RENAL DIALYSIS; T-LYMPHOCYTES; UREMIA;

EID: 0343294375     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.4.502     Document Type: Article

References (38)

1. White E. Life, death and the pursuit of apoptosis. Genes Dev 1996; 10: 1-15
2. Lopez-Hoyos M, Carrio R, Merino J, Merino R. Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases (Review). Int J Mol Med 1998; 1: 475-483
3. Nuñez G, Merino R, Grillot D, Gonzalez-Garcia M. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 1994; 15: 582-588
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462
5. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. J Am Med Assoc 1998; 279: 300-307
6. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. The immune system dysregulation in uraemia. Semin Nephrol 1994; 14: 253-260
7. Dammin GJ, Couch NP, Murray JE. Prolonged survival of skin homografts in uraemic patients. Ann N Y Acad Sci 1957; 64: 967-976
8. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeir TJ, Najarian JS. Increased incidence of malignancy during chronic renal failure. Lancet 1975; 1: 883-886
9. Cappel R, Van Beers D, Liesnard C, Dratwa M. Impaired humoral and cell-mediated immune responses in dialized patients after influenza vaccination. Nephron 1983; 33: 21-25
10. Stevens CE, Alter MD, Taylor PE, Zang EA, Harley EJ, Sztiuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984; 311: 496-500
11. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996; 16: 183-191
12. Heidenreich S, Schmidt M, Bachmann J, Harrach B. Apoptosis or monocytcs cultured from long-term hemodialysis patients. Kidney Int 1996; 49: 792-799
13. Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Aljama P. Nonbiocompatible hemodialysis membranes induce apoptosis in mononuclear cells: the role of G-proteins. J Am Soc Nephrol 1998; 9:46-53
14. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ. Neutrophil apoptosis and dysfunction in uraemia. J Am Soc Nephrol 1999; 10: 93-100
15. Hengartner MO. Programmed cell death in vertebrates. Curr Opin Gen Dev 1996; 6: 34-38
16. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781-828
17. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1455
18. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365
19. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39-42
20. Chao DT, Korsmeyer SJ, Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998; 16: 395-419
21. Fraker PJ, King LE, Lill-Elghanian D, Telford WG. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. In: Schwartz LM, Osborne BA, eds Cell Death. Academic Press, London: 1995: 57-76
22. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2 and Bax. J Immunol 1998; 160: 1627-1637
23. Merino R, Ding L, Veis DJ, Korsmeyer SJ, Núñez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994; 13: 683-691
24. + T lymphocytes during HIV infection. J Immunol 1996; 156: 2282-2293
25. Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon M-L. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998; 160: 3194-3206
26. Raska KJR, Raskova J, Shea SM et al. T cells subsets and cellular immunity in end-stage renal disease. Am J Med 1983; 75: 734-740
27. Kurz P, Köhler H, Meuer S, Hütteroth T, Meyer zum Büschenfelde KH. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 1986; 29: 1209-1214
28. Deenitchina SS, Ando T, Kinukawa N, Hirakata H, Nagashima A, Fujishima M. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995; 15: 57-65
29. Degiannis D, Mowat AM, Galloway E et al. In-vitro analysis of B lymphocyte function in uraemia. Clin Exp Immunol 1987; 70: 463-470
30. Raskova J, Ghobrial Y, Czerwinsky DK, Shea SM, Eisinger RP, Raska K. B-cell activation and immunoregulation in endstage renal disease patients receiving hemodialysis. Arch Inter Med 1987; 147: 89-93
31. Grooteman MP, Nube MJ, van Limbeek J, Schoorl M, van Houte AJ. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility? Nephrol Dial Transplant 1996; 11: 1073-1078
32. Matsumoto Y, Shinzato T, Amano Y et al. Relationship between susceptibility to apoptosis and fas expression in peripheral blood T cells from uraemic patients: A possible mechanism for lymphopenia in chronic renal failure. Biochem Bioph Res Comm 1995; 215: 98-105
33. Brunner T, Mogil RJ, LaFace D et al. Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 1995; 373: 441-444
34. Ju ST, Panka DJ, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-448
35. Zamauskaite A, Perez-Cruz I, Yaqoob MM, Madrigal JA, Cohen SBA. Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant 1999: 14: 49-55
36. Lomo J, Blomhoff HK, Jacobsen SE et al. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 1997; 89: 4415-4424
37. Bovia F, Nabili-Tehrani AC, Werner-Favre C et al. Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels. Eur J Immunol 1998; 28: 4418-4423
38. Tomayko MM, Cancro MP. Long-lived B cells are distinguished by elevated expression of A1. J Immunol 1998: 160: 107-111